Dominik Thimm

Title: Dominik Thimm: Innovator in Pharmaceutical Research

Introduction

Dominik Thimm is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of pharmaceutical research, particularly in the development of receptor antagonists. His work focuses on innovative methods for treating diseases associated with specific receptors.

Latest Patents

Thimm holds a patent for MRGX receptor antagonists. This invention relates to a method for preventing or treating diseases or disorders associated with the MrgX2 receptor. It also encompasses MrgX2 antagonists and their physiologically acceptable salts. Additionally, the invention includes pharmaceutical compositions and dosage forms that comprise an MrgX2 antagonist. He has 1 patent to his name.

Career Highlights

Throughout his career, Dominik Thimm has worked at prestigious institutions such as Rheinische Friedrich-Wilhelms-Universität Bonn and Katholieke Universiteit Leuven (KU Leuven) Research & Development. His experience in these organizations has allowed him to contribute to groundbreaking research in the pharmaceutical field.

Collaborations

Thimm has collaborated with esteemed colleagues, including Christa Müller and Mohamad Wessam Alnouri. These partnerships have further enhanced his research and innovation efforts.

Conclusion

Dominik Thimm is a prominent figure in pharmaceutical innovation, with a focus on receptor antagonists that hold promise for treating various diseases. His contributions to the field are noteworthy and continue to impact medical research positively.